trial · primary record
Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
Rabies
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 3000 |
| Primary completion | 2027-04-26 |
| Primary endpoint | Seroconversion rate and geometric mean concentration (GMC) of rabies virus neutralizing antibodies in baseline seronegative participants 14 days after the first dose. |
| Registry ID | NCT07275645 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:40:50.237Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07275645
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.